Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting

NCT01175330 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

39

Enrollment

NETWORK

Sponsor class

Stopped Interim analysis did not reveal of anticipated benefits of intervention

Conditions

Ischemic Heart Disease
Atrial Fibrillation

Interventions

DRUG: Omega-3 fish oil emulsion (Omegaven)
DRUG: Intralipid

Sponsor

Meshalkin Research Institute of Pathology of Circulation